[1] |
Chistiakov DA. Ligase Ⅳ syndrome[J]. Adv Exp Med Biol, 2010,685:175⁃185. doi: 10.1007/978⁃1⁃4419⁃6448⁃9_16.
|
[2] |
Wei YF, Robins P, Carter K, et al. Molecular cloning and expression of human cDNAs encoding a novel DNA ligase Ⅳ and DNA ligaseⅢ, an enzyme active in DNA repair and recombination[J]. Mol Cell Biol, 1995,15(6):3206⁃3216. doi: 10.1128/MCB.15.6.3206.
|
[3] |
Unal S, Cerosaletti K, Uckan⁃Cetinkaya D, et al. A novel mutation in a family with DNA ligase Ⅳ deficiency syndrome[J]. Pediatr Blood Cancer, 2009,53(3):482⁃484. doi: 10.1002/pbc.22031.
|
[4] |
Buck D, Moshous D, de Chasseval R, et al. Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase Ⅳ[J]. Eur J Immunol, 2006,36(1):224⁃235. doi: 10.1002/eji.200535401.
|
[5] |
Enders A, Fisch P, Schwarz K, et al. A severe form of human combined immunodeficiency due to mutations in DNA ligase Ⅳ[J]. J Immunol, 2006,176(8):5060⁃5068. doi: 10.4049/jimmunol. 176.8.5060.
|
[6] |
van der Burg M, van Veelen LR, Verkaik NS, et al. A new type of radiosensitive T⁃B⁃NK+ severe combined immunodeficiency caused by a LIG4 mutation[J]. J Clin Invest, 2006,116(1):137⁃145. doi: 10.1172/JCI26121.
|
[7] |
Murray JE, Bicknell LS, Yigit G, et al. Extreme growth failure is a common presentation of ligase IV deficiency[J]. Hum Mutat, 2014,35(1):76⁃85. doi: 10.1002/humu.22461.
|
[8] |
Altmann T, Gennery AR. DNA ligase Ⅳ syndrome; a review[J]. Orphanet J Rare Dis, 2016,11(1):137. doi: 10.1186/s13023⁃016⁃0520⁃1.
|
[9] |
Sun B, Chen Q, Wang Y, et al. LIG4 syndrome: clinical and molecular characterization in a Chinese cohort[J]. Orphanet J Rare Dis, 2020,15(1):131. doi: 10.1186/s13023⁃020⁃01411⁃x.
|
[10] |
Jiang J, Tang W, An Y, et al. Molecular and immunological characterization of DNA ligase Ⅳ deficiency[J]. Clin Immunol, 2016,163:75⁃83. doi: 10.1016/j.clim.2015.12.016.
|
[11] |
Riballo E, Doherty AJ, Dai Y, et al. Cellular and biochemical impact of a mutation in DNA ligase Ⅳ conferring clinical radiosensitivity[J]. J Biol Chem, 2001,276(33):31124⁃31132. doi: 10.1074/jbc.M103866200.
|
[12] |
Roddam PL, Rollinson S, O′Driscoll M, et al. Genetic variants of NHEJ DNA ligase Ⅳ can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination[J]. J Med Genet, 2002,39(12):900⁃905. doi: 10.1136/jmg.39.12.900.
|
[13] |
Cowan MJ, Gennery AR. Radiation⁃sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation⁃⁃what to do?[J] J Allergy Clin Immunol, 2015,136(5):1178⁃1185. doi: 10.1016/j.jaci.2015.04.027.
|
[14] |
O′Driscoll M, Jeggo PA. CsA can induce DNA double⁃strand breaks: implications for BMT regimens particularly for individuals with defective DNA repair[J]. Bone Marrow Transplant, 2008,41(11):983⁃989. doi: 10.1038/bmt.2008.18.
|